Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A plasmid-based reverse genetics system for influenza A virus

S Pleschka1, R Jaskunas, O G Engelhardt

  • 1Department of Microbiology, Mount Sinai School of Medicine, New York 10029, USA.

Journal of Virology
|June 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Citraconate inhibits ACOD1 (IRG1) catalysis, reduces interferon responses and oxidative stress, and modulates inflammation and cell metabolism.

Nature metabolism·2022
Same author

COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models.

Research square·2021
Same author

Subcellular Localizations of RIG-I, TRIM25, and MAVS Complexes.

Journal of virology·2016
Same author

Introduction and enzootic of A/H5N1 in Egypt: Virus evolution, pathogenicity and vaccine efficacy ten years on.

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases·2016
Same author

Model of influenza A virus infection: dynamics of viral antagonism and innate immune response.

Journal of theoretical biology·2014
Same author

Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses.

Journal of virology·2013

Researchers developed a new plasmid-based reverse genetics system for influenza viruses. This efficient method allows intracellular reconstitution of ribonucleoprotein (RNP) complexes for studying viral RNA replication.

Area of Science:

  • Virology
  • Molecular Biology
  • Genetics

Background:

  • Reverse genetics systems are crucial for studying negative-strand RNA viruses like influenza.
  • Previous methods involved transfecting pre-formed ribonucleoprotein (RNP) complexes into infected cells.
  • A more convenient system for intracellular RNP reconstitution was needed.

Purpose of the Study:

  • To develop a novel, exclusively plasmid-driven reverse genetics system for influenza viruses.
  • To enable efficient intracellular reconstitution of viral ribonucleoprotein (RNP) complexes.
  • To facilitate the study of cis- and trans-acting signals in influenza virus RNA transcription and replication.

Main Methods:

  • Developed a system using plasmid-based expression vectors for intracellular RNP reconstitution.

Related Experiment Videos

  • Utilized a truncated human polymerase I (polI) promoter for viral RNA-like transcript expression.
  • Co-transfected polI-driven plasmids with polII-responsive plasmids expressing viral proteins (PB1, PB2, PA, NP) into human 293 cells.

    • Main Results:

    • Achieved efficient transcription and replication of a viral RNA-like reporter construct.
    • Demonstrated the system's utility by rescuing a synthetic neuraminidase gene into a recombinant influenza virus.
    • The plasmid-driven system proved to be a convenient alternative to RNP transfection.

    Conclusions:

    • The developed system allows for efficient intracellular reconstitution of influenza virus RNPs from plasmids.
    • This novel reverse genetics approach simplifies the study of viral RNA transcription and replication mechanisms.
    • The system offers a convenient and effective alternative for influenza virus reverse genetics research.